SCHEMBL17015933

SCHEMBL17015933

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2ccc(-n3c4ccccc4c4ccc5cc(-c6ccccc6)n(-c6ccccc6)c5c43)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ TSPO P30536 2/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HAO1 Q9UJM8 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ RAC2 P15153 1/20 0.34
▸ RAC3 P60763 1/20 0.34
▸ CDC42 P60953 1/20 0.34
▸ RAC1 P63000 1/20 0.34
▸ PTGER4 P35408 1/20 0.34
▸ APP P05067 1/20 0.33
▸ NR3C1 P04150 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ IL1R1 P14778 1/20 0.33
▸ HTT P42858 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17015953 1.00 L3MBTL1 (0.43) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17015947 0.95 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17015944 0.95 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17015957 0.94 L3MBTL1 (0.40) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17015948 0.94 L3MBTL1 (0.40) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17015937 0.94 L3MBTL1 (0.44) L3MBTL1KDM4EATMHDAC4HAO1
SCHEMBL17015881 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL17015885 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPOHDAC4
SCHEMBL15632271 0.94 L3MBTL1 (0.45) L3MBTL1KDM4EATMHDAC4HAO1
SCHEMBL17015942 0.93 L3MBTL1 (0.50) L3MBTL1KDM4EATMHDAC4HAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 — — US disclosed
US-9837618-B2 Compound and organic electroluminescence device including thesame DOOSAN CORPORATION (KR) 2017-12-05 — — US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 — — US disclosed
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME DOOSAN CORPORATION (KR) 2015-08-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236272-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME INMT, IDO1, IDO2 L3MBTL1 533/4885KDM4E 1286/4885ATM 3623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback